GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Samples Without DNA

Company
Assistance Publique - Hôpitaux de Paris
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Samples Without DNA and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07554183

    4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis

    Not yet reported Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2028-05-01 2 sites Stand-alone
    Other conditions: Cirrhosis, Portal Hypertension
    View official trial listing →
  • Completed NCT NCT04920162

    Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma

    Not yet reported Centre Hospitalier Universitaire de Nice 10 participants Est. completion 2024-04-05 1 site
    Other conditions: Melanoma and Vitiligo
    View official trial listing →
  • Completed NCT NCT05311033

    Evaluation of a Tranexamoc Acid Treatment on Post-inflammatory Pigmentation in the Suction Blister Model

    Not yet reported Centre Hospitalier Universitaire de Nice 10 participants Est. completion 2025-08-18 1 site Stand-alone
    Other conditions: Skin Pigmentation
    View official trial listing →
  • Active, not recruiting NCT NCT06133907

    Investigation of the Frequency of Hereditary Hyper Alpha-tryptasemia in Patients With Elevated Basal Tryptasemia

    Not yet reported Centre Hospitalier Universitaire de Nice 100 participants Est. completion 2027-03-01 1 site Stand-alone
    Other conditions: Allergic Bronchiolitis
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.